Send to

Choose Destination
Biol Open. 2016 Nov 15;5(11):1595-1606. doi: 10.1242/bio.019208.

Lethal lung hypoplasia and vascular defects in mice with conditional Foxf1 overexpression.

Author information

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Program in Translational Biology & Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.
Institute of Informatics, University of Warsaw, Warsaw 02-097, Poland.
Division of Pulmonary Biology, Cincinnati Children's Hospital Research Foundation, Cincinnati, OH 45229, USA.
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Genetics & Genome Biology Program, SickKids, Toronto, Ontario M5G 0A4, Canada.
Department of Molecular Physiology & Biophysics, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA


FOXF1 heterozygous point mutations and genomic deletions have been reported in newborns with the neonatally lethal lung developmental disorder, alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV). However, no gain-of-function mutations in FOXF1 have been identified yet in any human disease conditions. To study the effects of FOXF1 overexpression in lung development, we generated a Foxf1 overexpression mouse model by knocking-in a Cre-inducible Foxf1 allele into the ROSA26 (R26) locus. The mice were phenotyped using micro-computed tomography (micro-CT), head-out plethysmography, ChIP-seq and transcriptome analyses, immunohistochemistry, and lung histopathology. Thirty-five percent of heterozygous R26-Lox-Stop-Lox (LSL)-Foxf1 embryonic day (E)15.5 embryos exhibit subcutaneous edema, hemorrhages and die perinatally when bred to Tie2-cre mice, which targets Foxf1 overexpression to endothelial and hematopoietic cells. Histopathological and micro-CT evaluations revealed that R26Foxf1; Tie2-cre embryos have immature lungs with a diminished vascular network. Neonates exhibited respiratory deficits verified by detailed plethysmography studies. ChIP-seq and transcriptome analyses in E18.5 lungs identified Sox11, Ghr, Ednrb, and Slit2 as potential downstream targets of FOXF1. Our study shows that overexpression of the highly dosage-sensitive Foxf1 impairs lung development and causes vascular abnormalities. This has important clinical implications when considering potential gene therapy approaches to treat disorders of FOXF1 abnormal dosage, such as ACDMPV.


ACDMPV; Lung development; Pulmonary vasculature

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center